Hypermutant Cancers Trial

Viewing: SA

Filter by

Trial Stage
  • Trial Stage
  • Closed to Recruitment
  • In Development
  • Open
  • Preparing to Open
Location
  • Location
  • New Zealand
  • NSW
  • QLD
  • SA
  • TAS
  • VIC
  • WA
Disease Type
  • Disease Type
  • Bone Cancers (Ewing Sarcoma/Osteosarcoma)
  • Brain and other Central Nervous System (CNS) Tumours
  • Germ Cell Tumours
  • Hodgkin Lymphoma
  • Kidney (Renal) Tumours
  • Leukaemia
  • Liver tumours
  • Neuroblastoma
  • Non-Hodgkin Lymphoma
  • Other
  • Soft Tissue Sarcomas
Disease Stage
  • Disease Stage
  • Newly diagnosed
  • Other
  • Relapsed/Recurrent

Hypermutant Cancers Trial

Other

A Pilot Study of Nivolumab in Paediatric Patients with Hypermutant Cancers

Relapsed/Recurrent
Read more

TINT

Other
Status: Open | NSW, QLD, SA, TAS, VIC, WA

A phase II study of trametinib in paediatric, adolescent and young adult patients with Neurofibromatosis type 1 associated plexiform neurofibromas or progressive optic pathway gliomas.

Other
Read more

MNP2.0

Brain and other Central Nervous System (CNS) Tumours

Molecular Neuropathology 2.0

Newly diagnosed
Read more

SIOPEN SCI Registry

Neuroblastoma
Status: Open | NSW, QLD, SA, TAS, VIC, WA

Prospective Study Registry of Peripheral Neuroblastic Tumours Presenting with Spinal Canal Involvement

Newly diagnosed
Read more

PNOC-022 (DMG-ACT)

Brain and other Central Nervous System (CNS) Tumours
Status: Open | New Zealand, NSW, QLD, SA, VIC, WA

A Combination Therapy Trial using an Adaptive Platform Design for Children and Young Adults with Diffuse Midline Gliomas including Diffuse Intrinsic Pontine Gliomas at Initial Diagnosis, Post-Radiation Therapy and at Time of Progression.

Newly diagnosed, Relapsed/Recurrent
Read more

All posts loaded.

All posts loaded.

Join our newsletter

"*" indicates required fields

This field is for validation purposes and should be left unchanged.

Email info@anzchog.org   |  

Level 6, TRF Building, Hudson Institute, 27-31 Wright St, Clayton VIC 3168